Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2681 |
|
Actual shortage: | 250 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2422 (90%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
25 (10%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-ESOMEPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2022-12-15 | 2023-10-04 | 178524 |
TEVA-PROPRANOLOL | 40MG | TABLET | Resolved | 2022-12-15 | 2023-07-06 | 178530 |
TEVA-SIMVASTATIN | 40MG | TABLET | Resolved | 2023-01-12 | 2023-07-12 | 180912 |
TEVA-ROSUVASTATIN | 40MG | TABLET | Resolved | 2023-02-02 | 2023-02-09 | 183425 |
TEVA-TELMISARTAN | 40MG | TABLET | Resolved | 2023-02-09 | 2023-04-28 | 184171 |
TEVA-FUROSEMIDE | 40MG | TABLET | Resolved | 2023-02-09 | 2023-06-09 | 184174 |
TEVA-PROPRANOLOL | 40MG | TABLET | Resolved | 2023-02-09 | 2023-07-12 | 184180 |
TEVA-PANTOPRAZOLE MAGNESIUM | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2023-04-27 | 2023-12-14 | 190770 |
TEVA-ROSUVASTATIN | 40MG | TABLET | Resolved | 2023-06-08 | 2023-07-05 | 194151 |
TEVA-ESOMEPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2023-06-16 | 2024-01-19 | 195052 |
TEVA-ROSUVASTATIN | 40MG | TABLET | Resolved | 2023-06-16 | 2023-10-03 | 195103 |
TEVA-SIMVASTATIN | 40MG | TABLET | Resolved | 2023-06-16 | 2023-06-21 | 195243 |
TEVA-FLUVASTATIN | 40MG | CAPSULE | Resolved | 2023-06-19 | 2023-07-05 | 195429 |
TEVA-PROPRANOLOL | 40MG | TABLET | Resolved | 2023-06-19 | 2023-07-05 | 195612 |
TEVA-ROSUVASTATIN | 40MG | TABLET | Resolved | 2023-06-19 | 2023-08-04 | 195621 |
TEVA-PANTOPRAZOLE MAGNESIUM | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2023-06-20 | 2023-07-05 | 195800 |
TEVA-PROPRANOLOL | 40MG | TABLET | Resolved | 2023-06-20 | 2023-07-05 | 195821 |
TEVA-TELMISARTAN | 40MG | TABLET | Resolved | 2023-07-20 | 2024-04-25 | 199393 |
TEVA-PRAVASTATIN | 40MG | TABLET | Resolved | 2023-10-05 | 2024-01-11 | 206395 |
TEVA-SIMVASTATIN | 40MG | TABLET | Actual shortage | 2023-10-19 | 2024-05-09 | 207518 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81337 | ||
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81344 | ||
HYDROCORTISONE SODIUM SUCCINATE INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81347 | ||
TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106136 | ||
TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106139 | ||
RATIO-SALBUTAMOL | Discontinued | 2020-02-13 | 2020-02-13 | 106151 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106155 | ||
EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106170 | ||
LINEZOLID INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106173 | ||
EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106176 |